Severe Hemophilia B
Also known as: Severe Haemophilia B / Hemophilia B, Severe
Drug | Drug Name | Drug Description |
---|---|---|
DB16791 | Etranacogene dezaparvovec | An adeno-associated virus vector-based gene therapy used for the treatment of hemophilia B (congenital factor IX deficiency). |
DB16783 | Fidanacogene elaparvovec | In Canada and the US, fidanacogene elaparvovec is indicated for the treatment of adults (aged 18 years or older) with moderately severe to severe Hemophilia B (congenital Factor IX deficiency)... |
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00100 | Coagulation Factor IX (Recombinant) | 3 | Completed | 2 |
DB13152 | Coagulation Factor IX Human | 3 | Completed | 1 |
DB11608 | Eftrenonacog alfa | 3 | Completed | 2 |